Omega Therapeutics Inc (NAS:OMGA)
$ 1.47 -0.04 (-2.65%) Market Cap: 81.08 Mil Enterprise Value: 162.18 Mil PE Ratio: 0 PB Ratio: 3.21 GF Score: 30/100

Omega Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 05:45PM GMT
Release Date Price: $4.35 (-13.69%)
Dave Pror JPMorgan;Analyst

Good morning, and welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is Dave prior Roche, and I'm part of the healthcare investment banking team here at JPMorgan. Today, I have the pleasure of introducing our speaker, Mahesh Karande, CEO of Omega Therapeutics. And also on the podium, we have CSO, Thomas McCauley, who will be participating in the Q&A. In terms of logistics for today. Please reserve any questions for after the presentation. Mike will be passed around with that, take it away, Mahesh.

Mahesh Karande
Omega Therapeutics Inc - President, Chief Executive Officer, Director

Thank you very much and thanks to JPMorgan for having me and Omega therapeutics here, actually, it's a pretty exciting week for Omega. We are we are a clinical-stage biotech company that is working on the first use of programmable IP. genomic medicines. Mrna therapeutics has programmable every genomic medicines in. So as a young company that's been around for a little over five years and already in the clinic, it was tremendous

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot